Article Text

Download PDFPDF
Outcomes of 23- and 25-gauge transconjunctival sutureless vitrectomies for idiopathic macular holes
  1. S Kusuhara1,
  2. S Ooto1,
  3. D Kimura1,
  4. K Itoi1,
  5. H Mukuno1,
  6. N Miyamoto1,
  7. M Akimoto1,
  8. S Kuriyama2,
  9. H Takagi1
  1. 1
    Department of Ophthalmology, Hyogo Prefectural Amagasaki Hospital, Amagasaki, Hyogo, Japan
  2. 2
    Department of Ophthalmology, Otsu Red-Cross Hospital, Otsu, Shiga, Japan
  1. Dr H Takagi, Department of Ophthalmology, Hyogo Prefectural Amagasaki Hospital, 1-1-1 Higashi-Daimotsu-cho, Amagasaki, Hyogo 660-0828, Japan; takagi{at}hp.pref.hyogo.jp

Abstract

Background/aims: To assess the outcomes of 23-gauge sutureless transconjunctival vitrectomies (TSV), as compared with 25-gauge TSV in macular hole surgeries.

Methods: A retrospective, consecutive, interventional case series of 47 eyes with idiopathic macular holes treated by 23- or 25-gauge TSV were analysed.

Results: The operative time was 37.2 (SD 8.9) min with 23-gauge TSV and 34.2 (8.7) min with 25-gauge TSV (p = 0.388). The anatomical success rate was 96% with 23-gauge TSV and 92% with 25-gauge TSV (p>0.999). The logarithm of the minimum angle of resolution of best-corrected visual acuity (BCVA) at the sixth postoperative month was 0.19 (0.16) with 23-gauge TSV and 0.19 (0.25) with 25-gauge TSV (p = 0.521). Postoperative improvement in BCVA was comparable between the two TSVs. IOP on postoperative day 1 was lower with 25-gauge TSV (12.3 (4.9) mm Hg) than with 23-gauge TSV (17.4 (5.8) mm Hg) (p = 0.036). Complications included retinal break, intraoperative bleeding and slippage of the infusion cannula with 23-gauge TSV, while retinal detachment and postoperative hypotony occurred in the 25-gauge TSV group (p = 0.570).

Conclusion: 23-gauge TSV appears to be as safe and effective as 25-gauge TSV in macular hole surgery.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • The first two authors contributed equally.

  • Competing interests: None.

  • Ethics approval: This study was approved by the Institutional Review Board and conducted in accordance with the tenet of Declaration of Helsinki.

  • Patient consent: Obtained.